Home › Multiple Sclerosis › Florida › Naples
Multiple Sclerosis clinical trials in Naples, FL
4 studies for Multiple Sclerosis are looking for participants at sites in and around Naples (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
RecruitingObservational study
- TG Therapeutics Investigational Trial Site, Naples
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
RecruitingPhase 3
- Aqualane Clinical Research- Site Number : 8400026, Naples
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
RecruitingPhase 2
- Aqualane Clinical Research, Naples
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
RecruitingPhase 3
- Aqualane Clinical Research, Naples
About Multiple Sclerosis
Multiple sclerosis (MS) slows down or blocks messages between the brain and body. MS can be mild or severe. Learn about MS symptoms and treatment.
More about Multiple Sclerosis on MedlinePlus
Multiple Sclerosis trials in other cities
- New York City, NY17 studies
- Chicago, IL15 studies
- Boston, MA14 studies
- Washington, DC13 studies
- Cleveland, OH9 studies
- St. Louis, MO8 studies
- Kansas City, KS8 studies
- Birmingham, AL8 studies
- San Francisco, CA8 studies
- Seattle, WA7 studies
- Columbus, OH7 studies
- Baltimore, MD7 studies
Other studies in Naples
- Alzheimer's Disease7 studies
- Interstitial Lung Diseases5 studies
- Cardiovascular Disease4 studies
- Obesity4 studies
- Overweight4 studies
- Major Depressive Disorder3 studies
- Neurologic Diseases3 studies
- Psychotic Disorders3 studies
- Parkinson's Disease3 studies
- Pulmonary Hypertension3 studies
- Aortic Valve Stenosis3 studies
- Atrial Fibrillation3 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.